Article Information
vol. 7 no. 4
Published By
Online ISSN
History
- Received June 11, 2021
- Accepted September 29, 2021
- Published online November 22, 2021.
Article Versions
- previous version (November 4, 2021 - 09:00).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Gavin C. Donaldson1⇑,
- Andrew I. Ritchie1,
- Peter M.A. Calverley2,
- Jorgen Vestbo3,
- Malin Fageras4,
- Alberto de la Hoz5,
- Enrica Bucchioni6,
- Chris H. Compton7,
- Karen Mezzi8 and
- Jadwiga A. Wedzicha1
- on behalf of the BLF Early COPD Partnership
- 1National Heart and Lung Institute, Imperial College London, London, UK
- 2University Hospital Aintree, University of Liverpool, Liverpool, UK
- 3Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK
- 4Astra-Zeneca, Gothenburg, Sweden
- 5Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
- 6Chiesi, Parma, Italy
- 7GSK, Brentford, UK
- 8Novartis Pharma AG, Basel, Switzerland
- Gavin C. Donaldson (gavin.donaldson{at}imperial.ac.uk)
Funding
Boehringer Ingelheim
Chiesi Farmaceutici
Novartis
AstraZeneca
GlaxoSmithKline
